secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001770787-25-000031
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics revenue ex-settlement falls 2% YoY; cuts 8% workforce, withdraws FY guidance
--------------------------------------------------------------------------------

- Q1 revenue $154.9M incl $16.8M patent settlement; ex-settlement $138.1M, down 2% YoY.
- Net loss $34.4M vs $59.9M YoY; operating loss $39.3M, improved from $61.5M.
- Cutting ~8% of global workforce; expects $5.5-6.5M severance in Q2 2025.
- Withdraws full-year 2025 guidance citing US academic/government funding uncertainty.
- Q2 2025 revenue guidance $138-142M (ex-settlement), 1% sequential growth at midpoint.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000031/0001770787-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000031/txg-20250506.htm
  HTML page:      https://secwatch.observer/filing/0001770787-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer